Knoferl et al “COX-2 mwdiatewd reguln . . . and subsequent sepsis”(PubMed Abstr. 11770048; also cited as Shock, 16/6,479-83(2001)).* |
Ribardo et al“Role of melittin-like region within phospholipase A(2)-activating protein . . . function”(PubMed Abstr. 11821123; also cited as Toxicon 405,519-26(2002)).* |
Hoozemans et al“Interleukin-1 beta induced COX-2 expression & prostaglandin E2 secretion . . . ”(PubMed Abstr. 11250126, also cited as Exp Gerontol, 36/3,559-70(2001)).* |
Joussen et al“Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha . . . ”(PubMed Abstr. 11821258; also cited as Faseb J. 16/3,438-40(2002)).* |
Baracos et al, N. Eng. J. Med. 308:553-558 (1983). |
Winter et al Proc. Soc. Exp. Biol. Med. (1962) vol. 111, p 544-547. |
Beutler et al, J. Immunol. 135(6):3969-3971 (1985). |
Borne, Handbook of Cardiovascular and Anti-Inflammatory Agents, p. 27-104 (1986). |
Brahn et al, Lymphokine Cytokine Res. (11):253-256, (1992). |
Evans et al., J. Biol. Chem. 270(19):11477-83, (1995). |
Guram & Buchwald et al., Angew. Chem. Int. Ed. Engl. 1348-1350 (1995). |
Stupnikova et al., Ukr. Kim. Zh., 48(1), 76-9(1982). |
Trentham et al J. Exp. Med. (1977) vol. 146, p 857-868. |
Arcadi et al., Tetrahedron, 46(20):7151-64 (1990). |
Wensbo et al., Tetrahedron Letters, 34(17):2823-2826 (1993). |
Chandrasekhar et al., Clinical Immunol. Immunopathol. 55:382-400 (1990). |
Swingle, K. F., in R. A. Scherrer and M. W. Whitehouse, Eds., Antiinflammatory Agents, Chemistry and Pharmacology, vol. 13-II, Academic, New York, 1974, p. 33-122, Chapter 2. |
Clouse et al, J. Immunol. 142(2):431-438 (1989). |
Cooper et al., Clin. Exp. Immunol. 89:244-250 (1992). |
Courtenay et al., Nature, vol. 283, p. 666-668 (1980). |
Shohami et al, J. Cereb. Blood Flow Metab. 14:615-619 (1994). |
Dinarello, Charles A., Eur. Cytokine Netw. 5:517-531 (1994). |
Shapiro et al., Proc. Natl. Acad. Sci. (USA) vol. 92, 12230-4 (1995). |
Maini et al., Immunological Reviews No. 144, p. 195-223 (1995). |
Liu et al., Neurosci. Lett. 164:125-128 (1993). |
Liu et al., Stroke 25(7):1481-1488 (1994). |
Beyaert et al., EMBO Journal, vol. 15, No. 8, p 1914-23 (1996). |
Firestein et al., Am. J. Pathol. 140(6):1309-1314, (1992). |
Folks et al, J. Immunol. 136(11):4049-4053, (1986). |
Fürstner et al, Tet. Lett., 32(46):6695-6696 (1991). |
Gallagher et al, Biorg. Med. Chem. Lett., 5(11):1171-1176 (1995). |
Gribble, G., Recent Developments in Indole Ring Synthesis-Methodology and Applications in Contemporary Organic Synthesis p. 145-172. |
Han et al., Biochimica Biophysica Acta 1265:224-227 (1995). |
Lee et al., Nature 372:739-746 (1994). |
Herbert et al., J. Chem. Soc. (C), p. 1505-1514(1969). |
Lee et al, Circulatory Shock 44:97-103 (1995). |
Lähdevirta et al, The American J. Med. 85:289-291 (1988). |
Stupnikova et al., Khim. Geterotsikl. Soedin., (7), 959-64 (1980). |
Joosten et al, Arthritis & Rheumatism 39(5):797-809 (1996). |
Bundgaard et al., J. Med. Chem., 32(12):2503-2507 (1989). |
Svensson et al., Drug Metabolism Reviews, 19(2):165-194 (1988). |
Bumagin et al., Synthesis, 728-729 (1984). |
Julia et al., J. Chem. Soc. Perkin Trans I, 1101-1105 (1991). |
Wrobel et al., Tet. Lett., 34(22):3543-3546 (1993). |
Jacini et al., Gazz. Chim. Ital, vol. 77:308-311 (1947). |
Park et al., Bull. Korean Chem. Soc., 13(4):357-359 (1992). |
Howbert et al., J. Med. Chem., 33:2393-2407 (1990). |
Curran et al., J. Org. Chem., 55:4585-4595 (1990). |
Trost et al., Tet. Lett., 22(14):1287-1290 (1981). |
Baldenius et al., Tet. Asymmetry, 1(9):597-610 (1990). |
Pascual, Bull. Soc. Chim. Belg., 101:297-302 (1992). |
Rumler et al., Pharmazie, 45(9):657-659 (1990). |
Farina et al., Tet. Lett., 32(34):4243-4246 (1991). |
Takeuchi et al., Synthesis, 923-924 (1990). |
Carlstrom et al., J. Org. Chem., 56:1289-1293 (1991). |
Carlstrom et al., Synthesis, 414-418 (1989). |
Bozell et al., J. Org. Chem., 56:2584-2587 (1991). |
Yamanaka et al., Chem. Pharm. Bull., 33(10):4309-4313 (1985). |
Girshovich et al., Zh. Org. Khim., 27(10):2235-2236 (1991). |
Bell et al., Synthesis, 843-844 (1987). |
Bell et al., Tet. Lett., 29(39):5013-5016 (1988). |
Siddiqui et al., Tet. Lett., 31(11):1523-1526 (1990). |
Iihama et al., Synthesis, 184-188 (1989). |
Hoshino et al., Bull. Chem. Soc. Jpn., 61:3008-3010 (1988). |
Sato et al., Chem. Lett., 1405-1408 (1989). |
Paul et al., J. Am. Chem. Soc., 5969-70 (1994). |
Guram et al., J. Am. Chem. Soc., 116:7901-7902 (1994). |
Davis et al., Tet. Lett., 32(13):1631-1634 (1991). |
Differding et al., Synlett., 187-189 (1991). |
Miyashita et al., Heterocycles, 42(2):691-699 (1996). |
Fürstner et al., J. Org. Chem., 59:5215-5229 (1994). |
Purohit et al., Indian Journal of Chemistry, vol. 32B, 257-261 (1993). |
Mendel et al., Chemical Abstracts, 112:716 (1990). |
Biere et al., Liebigs Ann. Chem., 491-494 (1987). |
Black et al., Synthesis, 474-476 (1986). |
Pichler et al., Liebigs Ann. Chem., 1485-1505 (1986). |
Stupnikova et al., Chemical Abstracts, 96:17, 738 (1982). |
Dave et al., J. Heterocyclic Chem., 17:1497-1500 (1980). |
Hardy et al., J. Chem. Soc., Perkin Trans. I., 506-511 (1980). |
Fenner et al., Arch. Pharm. (Weinheim) 311, 153-161 (1978). |
Roth et al., Arch. Pharm. (Weinheim) 308, 252-258 (1975). |
Clark et al., J. Chem. Soc., Perkin Trans I., 1361-1363 (1976). |
Bancroft et al., J. Chem. Soc., Perkin Trans I., 1852-1858 (1974). |
Deubel et al., Chem. Ber., 104, 705-716 (1971). |
Kelly et al., J. Chem. Soc., 303-307 (1970). |
Colonna et al., Gazz. Chim. Ital., vol. XCVI, 1410-1422 (1966). |
Bancroft et al., J.C.S. Perkin I, pp. 465-467 (1977). |
Saify et al., J. Pharm. Univ Kar., 1(1), 83-88 (1982). |
Monnet et al., J. Heterocyclic Chem. 26, pp. 1029-1037 (1988). |
Broderick et al., JCS Perkin I, pp. 1910-1913 (1975). |
Kelley et al., Canadian J. of Chem. vol. 44, pp. 2455-2459 (1966). |